{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:48:41Z","timestamp":1760233721480,"version":"build-2065373602"},"reference-count":17,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Herpes simplex virus type 1 and 2 (HSV1 and HSV2) are global, widespread human pathogens transmitted by direct contact that cause lifelong, recurrent asymptomatic and painful symptomatic clinical illnesses (cold sores, keratitis, blepharitis, meningitis, encephalitis, genital infections), overt disease and severe sequelae in neonatal and immune-compromised patients, and increased risk of cervical cancer and other sexually transmitted infections, including HIV [...]<\/jats:p>","DOI":"10.3390\/vaccines9020158","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T08:09:09Z","timestamp":1613462949000},"page":"158","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vaccine Development for Herpes Simplex Viruses: A Commentary of Special Issue Editors"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1241-0299","authenticated-orcid":false,"given":"Antonella","family":"Caputo","sequence":"first","affiliation":[{"name":"Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Fossato di Mortara 64\/b, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-0491","authenticated-orcid":false,"given":"Peggy","family":"Marconi","sequence":"additional","affiliation":[{"name":"Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Fossato di Mortara 64\/b, 44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/sti.2004.012039","article-title":"A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2","volume":"81","author":"Looker","year":"2005","journal-title":"Sex. Transm. Infect."},{"key":"ref_2","unstructured":"(2021, February 13). Neonatal Herpes Simplex Virus Infection Among Medicaid-Enrolled Children: 2009\u20132015. Available online: https:\/\/pediatrics.aappublications.org\/content\/143\/4\/e20183233."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"George, B.P., Schneider, E.B., and Venkatesan, A. (2014). Encephalitis hospitalization rates and inpatient mortality in the United States, 2000\u20132010. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104169"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/QCO.0000000000000175","article-title":"Acute encephalitis in the immunocompromised individual","volume":"28","author":"Saylor","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/14787210.2019.1656064","article-title":"Herpes simplex virus type 1 and Alzheimer\u2019s disease: Link and potential impact on treatment","volume":"17","author":"Mancuso","year":"2019","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_6","first-page":"2630865","article-title":"Herpes Simplex Virus Type 1 and Type 2 Infection Increases Atherosclerosis Risk: Evidence Based on a Meta-Analysis","volume":"2016","author":"Wu","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1016\/S2214-109X(16)30362-X","article-title":"First estimates of the global and regional incidence of neonatal herpes infection","volume":"5","author":"Looker","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/sextrans-2016-052921","article-title":"Does maternal HSV-2 coinfection increase mother-to-child transmission of HIV? A systematic review","volume":"93","author":"Sivarajah","year":"2017","journal-title":"Sex. Transm. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/infdis\/jiv017","article-title":"Risk of Bacterial Vaginosis Among Women With Herpes Simplex Virus Type 2 Infection: A Systematic Review and Meta-analysis","volume":"212","author":"Esber","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1016\/j.vaccine.2017.10.084","article-title":"Meeting report: Initial World Health Organization consultation on herpes simplex virus (HSV) vaccine preferred product characteristics, March 2017","volume":"37","author":"Gottlieb","year":"2019","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ike, A.C., Onu, C.J., Ononugbo, C.M., Reward, E.E., and Muo, S.O. (2020). Immune Response to Herpes Simplex Virus Infection and Vaccine Development. Vaccines, 8.","DOI":"10.3390\/vaccines8020302"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Aschner, C.B.B., Pierce, C., Knipe, D.M., and Herold, B.C. (2020). Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus. Vaccines, 8.","DOI":"10.3390\/vaccines8020277"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Voellmy, R., Bloom, D.C., and Vilaboa, N. (2020). Herpes Simplex Viruses Whose Replication Can Be Deliberately Controlled as Candidate Vaccines. Vaccines, 8.","DOI":"10.3390\/vaccines8020230"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mancuso, R., Cabinio, M., Agostini, S., Baglio, F., and Clerici, M. (2020). HSV-1-Specific IgG3 Titers Correlate with Brain Cortical Thinning in Individuals with Mild Cognitive Impairment and Alzheimer\u2019s Disease. Vaccines, 8.","DOI":"10.3390\/vaccines8020255"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Heilingloh, C.S., Lull, C., Kleiser, E., Alt, M., Schipper, L., Witzke, O., Trilling, M., Eis-H\u00fcbinger, A.-M., Dittmer, U., and Krawczyk, A. (2020). Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1. Vaccines, 8.","DOI":"10.3390\/vaccines8030478"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nicoli, F., Gallerani, E., Sicurella, M., Pacifico, S., Cafaro, A., Ensoli, B., Marconi, P., Caputo, A., and Gavioli, R. (2020). The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation. Vaccines, 8.","DOI":"10.3390\/vaccines8020274"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ayoub, H.H., Chemaitelly, H., and Abu-Raddad, L.J. (2020). Epidemiological Impact of Novel Preventive and Therapeutic HSV-2 Vaccination in the United States: Mathematical Modeling Analyses. Vaccines, 8.","DOI":"10.3390\/vaccines8030366"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/2\/158\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:24:53Z","timestamp":1760160293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/2\/158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["vaccines9020158"],"URL":"https:\/\/doi.org\/10.3390\/vaccines9020158","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2021,2,16]]}}}